Role of porins for uptake of antibiotics by Mycobacterium smegmatis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3127-3134

  Danilchanka, Olga ^a   Pavlenok, Mikhail ^a   Niederweis, Michael ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALORIDINE; CHLORAMPHENICOL; ERYTHROMYCIN; KANAMYCIN; NORFLOXACIN; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID MEMBRANE; MUTATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; CHLORAMPHENICOL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM SMEGMATIS; PORINS;

EID: 50949127310     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00239-08     Document Type: Article

References (60)

1. Barry, C. E., III, R. E. Lee, K. Mdluli, A. E. Sampson, B. G. Schroeder, R. A. Slayden, and Y. Yuan. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37:143-179.
2. Bedard, J., S. Wong, and L. E. Bryan. 1987. Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob. Agents Chemother. 31:1348-1354.
3. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
4. Chapman, J. S., and N. H. Georgopapadakou. 1988. Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother. 32:438-442.
5. Chevalier, J., M. Mallea, and J. M. Pages. 2000. Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae. Biochem. J. 348:223-227.
6. Chouchani, C., R. Berlemont, A. Masmoudi, M. Galleni, J. M. Frere, O. Belhadj, and K. Ben-Mahrez. 2006. A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica scrovar Infantis. Antimicrob. Agents Chemother. 50:3183-3185.
7. Collins, L., and S. G. Franzblau. 1997. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009.
8. Corti, S., J. Chevalier, and A. Cremieux. 1995. Intracellular accumulation of norfloxacin in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 39:2466-2471.
9. Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Pauptit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structures explain functional properties of two E. coli porins. Nature 358:727-733.
10. De Rossi, E., J. A. Ainsa, and G. Riccardi. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36-52.
11. Draper, P. 1998. The outer parts of the mycobacterial envelope as permeability barriers. Front. Biosci. 3:1253-1261.
12. Etienne, G., C. Villeneuve, H. Billman-Jacobe, C. Astarie-Dequeker, M. A. Dupont, and M. Daffe. 2002. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 148:3089-3100.
13. Faller, M., M. Niederweis, and G. E. Schulz. 2004. The structure of a mycobacterial outer-membrane channel. Science 303:1189-1192.
14. Flores, A. R., L. M. Parsons, and M. S. Pavelka, Jr. 2005. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 151: 521-532.
15. Franzblau, S. G., R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
16. Goldman, R. C., and F. Scaglione. 2004. The macrolide-bacterium interaction and its biological basis. Curr. Drug Targets Infect. Disord. 4:241-260.
17. Haemers, A., D. C. Leysen, W. Bollaert, M. Q. Zhang, and S. R. Pattyn. 1990. Influence of N substitution on antimycobacterial activity of ciprofloxacin. Antimicrob. Agents Chemother. 34:496-497.
18. Hancock, R. E., S. W. Farmer, Z. S. Li, and K. Poole. 1991. Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob. Agents Chemother. 35:1309-1314.
19. Harder, K. J., H. Nikaido, and M. Matsuhashi. 1981. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the OmpF porin. Antimicrob. Agents Chemother. 20:549-552.
20. Harries, A. D., and C. Dye. 2006. Tuberculosis. Ann. Trop. Med. Parasitol. 100:415-431.
21. Hoffmann, C., A. Leis, M. Niederweis, J. M. Plitzko, and H. Engelhardt. 2008. Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. USA 105:3963-3967.
22. Huang, H., and R. E. Hancock. 1996. The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa. J. Bacteriol. 178:3085-3090.
23. Jaffe, A., Y. A. Chabbert, and O. Semonin. 1982. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob. Agents Chemother. 22:942-948.
24. Jarlier, V., and H. Nikaido. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123:11-18.
25. Jarlier, V., and H. Nikaido. 1990. Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol. 172:1418-1423.
26. Koronakis, V., A. Sharff, E. Koronakis, B. Luisi, and C. Hughes. 2000. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914-919.
27. Luna-Herrera, J., G. Martinez-Cabrera, R. Parra-Maldonado, J. A. Enciso-Moreno, J. Torres-Lopez, F. Quesada-Pascual, R. Delgadillo-Polanco, and S. G. Franzblau. 2003. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 22:21-27.
28. Mailaender, C., N. Reiling, H. Engelhardt, S. Bossmann, S. Ehlers, and M. Niederweis. 2004. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis. Microbiology 150:853-864.
29. Malik, M., T. Lu, X. Zhao, A. Singh, C. M. Hattan, J. Domagala, R. Kerns, and K. Drlica. 2005. Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol. Antimicrob. Agents Chemother. 49:2008-2014.
30. McDonough, J. A., K. E. Hacker, A. R. Flores, M. S. Pavelka, Jr., and M. Braunstein. 2005. The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial beta-lactamases. J. Bacteriol. 187:7667-7679.
31. McLean, J. A. 1950. Streptomycin resistance in the tubercle bacillus. Edinburgh Med. J. 57:547-556.
32. Moadebi, S., C. K. Harder, M. J. Fitzgerald, K. R. Elwood, and F. Marra. 2007. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 67:2077-2099.
33. Mortimer, P. G., and L. J. Piddock. 1993. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J. Antimicrob. Chemother. 32:195-213.
34. Nguyen, L., and C. J. Thompson. 2006. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol. 14:304-312.
35. Niederweis, M. 2003. Mycobacterial porins - new channel proteins in unique outer membranes. Mol. Microbiol. 49:1167-1177.
36. Niederweis, M., S. Ehrt, C. Heinz, U. Klöcker, S. Karosi, K. M. Swiderek, L. W. Riley, and R. Benz. 1999. Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis. Mol. Microbiol. 33:933-945.
37. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.
38. Nikaido, H. 1992. Porins and specific channels of bacterial outer membranes. Mol. Microbiol. 6:435-442.
39. Nikaido, H., W. Liu, and E. Y. Rosenberg. 1990. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob. Agents Chemother. 34:337-342.
40. Nikaido, H., and E. Y. Rosenberg. 1981. Effect of solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. J. Gen. Physiol. 77:121-135.
41. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
42. Piddock, L. J., and V. Ricci. 2001. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. J. Antimicrob. Chemother. 48:787-791.
43. Portevin, D., C. De Sousa-D'Auria, C. Houssin, C. Grimaldi, M. Chami, M. Daffe, and C. Guilhot. 2004. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc. Natl. Acad. Sci. USA 101:314-319.
44. Raynaud, C., K. G. Papavinasasundaram, R. A. Speight, B. Springer, P. Sander, E. C. Böttger, M. J. Colston, and P. Draper. 2002. The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol. Microbiol. 46:191-201.
45. Renau, T. E., J. W. Gage, J. A. Dever, G. E. Roland, E. T. Joannides, M. A. Shapiro, J. P. Sanchez, S. J. Gracheck, J. M. Domagala, M. R. Jacobs, and R. C. Reynolds. 1996. Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrob. Agents Chemother. 40:2363-2368.
46. Renau, T. E., J. P. Sanchez, M. A. Shapiro, J. A. Dever, S. J. Gracheck, and J. M. Domagala. 1995. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J. Med. Chem. 38:2974-2977.
47. Robin, F., J. Delmas, C. Schweitzer, O. Tournilhac, O. Lesens, C. Chanal, and R. Bonnet. 2007. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient. Antimicrob. Agents Chemother. 51:1304-1309.
48. Sander, P., A. Meier, and E. C. Boettger. 1995. rpsL + : a dominant selectable marker for gene replacement in mycobacteria. Mol. Microbiol. 16:991-1000.
49. Schäfer, M., T. R. Schneider, and G. M. Sheldrick. 1996. Crystal structure of vancomycin. Structure 4:1509-1515.
50. Senaratne, R. H., H. Mobasheri, K. G. Papavinasasundaram, P. Jenner, E. J. Lea, and P. Draper. 1998. Expression of a gene for a porin-like protein of the OmpA family from Mycobacterium tuberculosis H37Rv. J. Bacteriol. 180:3541-3547.
51. Shah, N. S., A. Wright, G. H. Bai, L. Barrera, F. Boulahbal, N. Martin-Casabona, F. Drobniewski, C. Gilpin, M. Havelkova, R. Lepe, R. Lumb, B. Metchock, F. Portaels, M. F. Rodrigues, S. Rusch-Gerdes, A. Van Deun, V. Vincent, K. Laserson, C. Wells, and J. P. Cegielski. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13:380-387.
52. Stahl, C., S. Kubetzko, I. Kaps, S. Seeber, H. Engelhardt, and M. Niederweis. 2001. MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 40:451-464. (Author's correction, 57:1509.)
53. Stephan, J., J. Bender, F. Wolschendorf, C. Hoffmann, E. Roth, C. Mailänder, H. Engelhardt, and M. Niederweis. 2005. The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients. Mol. Microbiol. 58:714-730.
54. Stephan, J., C. Mailaender, G. Etienne, M. Daffe, and M. Niederweis. 2004. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:4163-4170.
55. Thanassi, D. G., G. S. Suh, and H. Nikaido. 1995. Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J. Bacteriol. 177:998-1007.
56. Wade, M. M., and Y. Zhang. 2004. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front. Biosci. 9:975-994.
57. Waksman, S. A. 1954. Tenth anniversary of the discovery of streptomycin, the first chemotherapeutic agent found to be effective against tuberculosis in humans. Am. Rev. Tuberc. 70:1-8.
58. Wang, L., R. A. Slayden, C. E. Barry III, and J. Liu. 2000. Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. J. Biol. Chem. 275:7224-7229.
59. Yew, W. W., K. S. Lau, W. K. Tse, and C. F. Wong. 1992. Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience. Clin. Infect. Dis. 15:1046-1047.
60. Zimmermann, W., and A. Rosselet. 1977. Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob. Agents Chemother. 12:368-372.